title: [Atypical and incomplete Kawasaki disease].
abstract: Kawasaki Disease (KD) is an acute systemic vasculitic disorder of childhood of unknown etiology. Initially KD was thought to be a benign disease, but later on it became obvious that cardiac manifestations are present in about 25-30% of patients and lead to death in about 0.5-2% of them. An early diagnosis and treatment are important to avoid an unfavourable prognosis. In recent years, a number of publications described patients in which the diagnosis was delayed because they did not fulfil the required criteria of KD. These forms of KD are known as atypical or incomplete KD. The aim of this work is to describe two cases of atypical KD observed at the Department of Pediatrics, University of Pisa during the year 1992.
authors.affiliation: Istituto di Clinica Pediatrica, Università degli Studi, Pisa.
authors.forename: V
authors.initials: V
authors.lastname: Rossomando
authors.forename: A
authors.initials: A
authors.lastname: Baracchini
authors.forename: G
authors.initials: G
authors.lastname: Chiaravalloti
authors.forename: N
authors.initials: N
authors.lastname: Assanta
authors.forename: G
authors.initials: G
authors.lastname: Buti
authors.forename: L
authors.initials: L
authors.lastname: Matteucci
authors.forename: M
authors.initials: M
authors.lastname: Ceccarelli
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007223:Infant; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000175:diagnosis* / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use
chemical_list: D016756:Immunoglobulins, Intravenous; D010975:Platelet Aggregation Inhibitors; D004176:Dipyridamole; D001241:Aspirin
vernacular_title: Le forme atipiche ed incomplete della malattia di Kawasaki.